TMDX Price / Book | TransMedics Group, Inc.

TransMedics Group, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

TransMedics Group, Inc. price/book ratio for the quarter ending 2026-06-30 was 4.44, a 69.01% decline year-over-year.
TransMedics Group, Inc. price/book ratio for the quarter ending 2026-03-31 was 6.95, a 18.71% decline year-over-year.
TransMedics Group, Inc. price/book ratio for the quarter ending 2025-12-31 was 8.81, a 3.88% decline year-over-year.
TransMedics Group, Inc. price/book ratio for the quarter ending 2025-09-30 was 10.79, a 57.03% decline year-over-year.
TransMedics Group, Inc. price/book ratio for fiscal 2026 was 4.44.
TransMedics Group, Inc. price/book ratio for fiscal 2025 was 8.81, a 3.88% decline from fiscal 2024.
TransMedics Group, Inc. price/book ratio for fiscal 2024 was 9.17, a 51.22% decline from fiscal 2023.
TransMedics Group, Inc. price/book ratio for fiscal 2023 was 18.79, a 77.53% increase from fiscal 2022.

Available history: 2019-06-29 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	4.44	$2.3B	$518.05M
2026-03-31	6.95	$3.43B	$494.01M
2025-12-31	8.81	$4.17B	$473.1M
2025-09-30	10.79	$3.83B	$355.2M
2025-06-30	14.34	$4.56B	$318.1M
2025-03-31	8.55	$2.28B	$266.31M
2024-12-31	9.17	$2.1B	$228.6M
2024-09-30	25.1	$5.27B	$209.92M
2024-06-30	26.42	$5.02B	$189.89M
2024-03-31	15.23	$2.43B	$159.47M
2023-12-31	18.79	$2.58B	$137.2M
2023-09-30	14.13	$1.79B	$126.46M
2023-06-30	18.84	$2.74B	$145.21M
2023-03-31	12.79	$2.46B	$192.63M
2022-12-31	10.59	$1.98B	$187.38M
2022-09-30	7.1	$1.33B	$187.86M
2022-06-30	17.31	$881.33M	$50.92M
2022-03-31	12.58	$753.47M	$59.91M
2021-12-31	7.85	$532.49M	$67.85M
2021-09-30	11.7	$918.74M	$78.55M
2021-06-30	10.31	$917.34M	$88.98M
2021-03-31	11.67	$1.14B	$97.68M
2020-12-31	5.21	$540.79M	$103.89M
2020-09-30	3.42	$374.25M	$109.55M
2020-06-30	4.27	$486.28M	$113.76M
2020-03-31	5.52	$257.83M	$46.68M
2019-12-28	7.21	$393.82M	$54.65M
2019-09-28	7.88	$500.31M	$63.47M
2019-06-29	8.6	$611.64M	$71.16M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	4.44	$2.3B	$518.05M
2025-12-31	8.81	$4.17B	$473.1M
2024-12-31	9.17	$2.1B	$228.6M
2023-12-31	18.79	$2.58B	$137.2M
2022-12-31	10.59	$1.98B	$187.38M
2021-12-31	7.85	$532.49M	$67.85M
2020-12-31	5.21	$540.79M	$103.89M
2019-12-28	7.21	$393.82M	$54.65M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Axogen, Inc. (AXGN)	United States	$2.329B	-73.83
BIOLIFE SOLUTIONS INC (BLFS)	United States	$1.887B	23.80
LivaNova PLC (LIVN)		$4.158B	24.01
Integer Holdings Corp (ITGR)	United States	$4.289B	25.17
CONMED Corp (CNMD)	United States	$1.353B	26.72
Ceribell, Inc. (CBLL)	United States	$0.916B	-11.27
CapsoVision, Inc (CV)	United States	$0.310B	-12.68
Electromed, Inc. (ELMD)	United States	$0.233B	31.13
EDAP TMS SA (FOCL)		$0.171B
Stereotaxis, Inc. (STXS)	United States	$0.130B	-7.53